Preclinical/Clinical Research Unit

Objectives

To market their products, SMEs in the healthcare sector in Türkiye must get approval from national and international bodies, such as EMA, FDA, and TİTCK. AnkaTheraHub offers valuable support to SMEs in planning their clinical research and completing the regulatory approval procedures. By gathering technologies and human resources within a single infrastructure, AnkaTheraHub is poised to make significant contributions to the field of theranostics.

Provided Services

AnkaTheraHub’s Preclinical and Clinical Research Unit provides crucial
services to the healthcare industry through a three-pronged approach:

incubation, innovation, business development, services, R&D
AnkaTheraHub is dedicated to promoting the R&D capacity of the healthcare industry in Türkiye, with a focus on SMEs to produce high-added and high-tech innovative theranostics products in the field of cancer and infectious diseases.